Refreshing results…
A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer.
Download from www.nature.comPD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma
UploadClinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancer
UploadPembrolizumab in men with heavily treated metastatic castrate‐resistant prostate cancer
Download from doi.orgMissing publications? Search for publications with a matching author name.